Determinants and Clinical Interpretation of Circulating Transthyretin in ATTR Amyloidosis
Authors:
- Toshihiro TsurudaTTToshihiro Tsuruda
- Yosuke SuikoYSYosuke Suiko
- Yunosuke MatsuuraYMYunosuke Matsuura
- Soichi KomakiSKSoichi Komaki
- Kohei MoribayashiKMKohei Moribayashi
- Hiroki TanakaHTHiroki Tanaka
- Masashi YamaguchiMYMasashi Yamaguchi
- Kinuko YamamotoKYKinuko Yamamoto
- Michikazu NakaiMNMichikazu Nakai
- Koichi KaikitaKKKoichi Kaikita
Open Access
- 28 August 2026
- journal article
- Published by Elsevier in JACC: Advances
- Vol. 5 (10)
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Serum Transthyretin as Prognostic Biomarker for Cardiovascular Events and MortalityJACC: Advances, 2025
- Transthyretin serum levels and clinical outcomes in patients with transthyretin amyloid cardiomyopathyEuropean Journal of Internal Medicine, 2025
- Inflammation in heart failure: pathophysiology and therapeutic strategiesInflammation Research, 2024
- Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel SyndromeJACC, 2022
- Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General PopulationJAMA Cardiology, 2021
- Transthyretin Amyloid CardiomyopathyJACC, 2019
- Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel ReleaseJACC, 2018
- Diagnostic Utility of Cardiac Troponin T Level in Patients with Cardiac AmyloidosisESC Heart Failure, 2017
- Is transthyretin a good marker of nutritional status?Clinical Nutrition, 2017
- Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: A practical, simple and clinically relevant approach in a large cohortJournal of Clinical Laboratory Analysis, 1999